Terms: = Lymphoma AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Diagnosis
24 results:
1. Key candidate genes and pathways in T lymphoblastic leukemia/lymphoma identified by bioinformatics and serological analyses.
Ren Y; Liang H; Huang Y; Miao Y; Li R; Qiang J; Wu L; Qi J; Li Y; Xia Y; Huang L; Wang S; Kong X; Zhou Y; Zhang Q; Zhu G
Front Immunol; 2024; 15():1341255. PubMed ID: 38464517
[TBL] [Abstract] [Full Text] [Related]
2. The obeticholic acid can positively regulate the cancerous behavior of MCF7 breast cancer cell line.
Rahmani R; Eivazi N; Emamgholipour S; Aminian M; Jalilian A; Paknejad M
Mol Biol Rep; 2024 Feb; 51(1):250. PubMed ID: 38302816
[TBL] [Abstract] [Full Text] [Related]
3. Pilot study on the effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on body composition in children with acute lymphoblastic leukemia: randomized clinical trial.
Barbosa-Cortés L; Martínez-Vieyra X; Mejía-Aranguré JM; López-Alarcón M; Martin-Trejo J; Delgadillo-Portillo S; Guzmán-Castro B; Delgadillo-Portillo J; Atilano-Miguel S; Rodríguez-Cruz M; Maldonado-Hernández J; Añoveros-Barrera A; Solís-Labastida KA; Espinoza-Hernández L; Nuñez-Villegas NN; Jiménez-Hernández E; Bautista-Martínez BA; Juárez-Moya A; Hernández-Piñón Z; Pérez-Casillas RX
Clin Nutr; 2023 Sep; 42(9):1759-1769. PubMed ID: 37549598
[TBL] [Abstract] [Full Text] [Related]
4. Effect of long-chain omega-3 polyunsaturated fatty acids on cardiometabolic factors in children with acute lymphoblastic leukemia undergoing treatment: a secondary analysis of a randomized controlled trial.
Barbosa-Cortes L; Atilano-Miguel S; Martin-Trejo JA; Jiménez-Aguayo E; Martínez-Becerril FI; López-Alarcón M; Mejía Aranguré JM; Maldonado-Hernández J; Delgadillo-Portillo S; Guzmán-Castro B; Delgadillo-Portillo J; Añoveros-Barrera A; Solis-Labastida KA; Bautista-Martinez BA; Juárez-Moya A; Hernández-Piñón Z; Espinoza Hernández LE; Núñez-Villegas NN; Jiménez-Hernández E; Pérez-Casillas RX
Front Endocrinol (Lausanne); 2023; 14():1120364. PubMed ID: 37124732
[TBL] [Abstract] [Full Text] [Related]
5. Detection and clinical significance of serum epo levels in patients with haematological tumours.
Zhao Y; Zhang W; Cong D; Bai Y
Cell Mol Biol (Noisy-le-grand); 2022 Nov; 68(11):33-36. PubMed ID: 37114311
[TBL] [Abstract] [Full Text] [Related]
6. Role of matrix metalloproteinase MMP-2, MMP-9 and tissue inhibitor of metalloproteinase (timp-1) in the clinical progression of pediatric acute lymphoblastic leukemia.
Saleh M; Khalil M; Abdellateif MS; Ebeid E; Madney Y; Kandeel EZ
Hematology; 2021 Dec; 26(1):758-768. PubMed ID: 34555302
[TBL] [Abstract] [Full Text] [Related]
7. Comparison of the Prognostic Ability of the HCT-CI, the Modified EBMT, and the EBMT-ADT Pre-transplant Risk Scores for Acute Leukemia.
Al-Shaibani E; Cyriac S; Chen S; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law A; Al-Shaibani Z; Gerbitz A; Pasic I; Mattsson J; Michelis FV
Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):e559-e568. PubMed ID: 33678592
[TBL] [Abstract] [Full Text] [Related]
8. Diagnostic Performance of Erythropoietin Levels in Polycythemia Vera: Experience at a Comprehensive Cancer Center.
Davila-Gonzalez D; Barrios-Ruiz A; Fountain E; Cheng L; Masarova L; Verstovsek S; Rojas-Hernandez CM
Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):224-229. PubMed ID: 33349602
[TBL] [Abstract] [Full Text] [Related]
9. MicroRNA-124a inhibits cell proliferation and migration in liver cancer by regulating interleukin-11.
Yu L; Wang S; Lin X; Lu Y; Gu P
Mol Med Rep; 2018 Mar; 17(3):3972-3978. PubMed ID: 29286137
[TBL] [Abstract] [Full Text] [Related]
10. Development of acute lymphoblastic leukemia with IgH-epoR in a patient with secondary erythrocytosis.
Sakamoto K; Tanaka S; Tomoyasu C; Tomii T; Yano M; Takagi K; Yasuhiko T; Uoshima N; Komatsu H; Imamura T
Int J Hematol; 2016 Dec; 104(6):741-743. PubMed ID: 27544511
[TBL] [Abstract] [Full Text] [Related]
11. [Differential diagnosis of anemia in true and functional iron deficiency in patients with chronic diseases (malignant tumors)].
Zubrikhina GN; Blindar VN; Matveeva II
Ter Arkh; 2016; 88(4):61-67. PubMed ID: 27070165
[TBL] [Abstract] [Full Text] [Related]
12. Cytokines, growth, and environment factors in bone marrow plasma of acute lymphoblastic leukemia pediatric patients.
Kováč M; Vášková M; Petráčková D; Pelková V; Mejstříková E; Kalina T; Žaliová M; Weiser J; Starý J; Hrušák O
Eur Cytokine Netw; 2014 Mar; 25(1):8-13. PubMed ID: 24998352
[TBL] [Abstract] [Full Text] [Related]
13. [The role of cytokines in lymphoma with anemia].
Wang T; Tu MF; Zhu J; Zheng W; Shao ZH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):392-5. PubMed ID: 23628039
[TBL] [Abstract] [Full Text] [Related]
14. [Plasma matrix metalloproteinases MMP-2 and MMP-9 and tissue inhibitors timp-1 and timp-2 in children treated for acute lymphoblastic leukemia].
Krawczuk-Rybak M; Kuźmicz M; Mroczko B; Szmitkowski M
Pol Merkur Lekarski; 2010 Jul; 29(169):14-8. PubMed ID: 20712241
[TBL] [Abstract] [Full Text] [Related]
15. In vitro secretion of matrix metalloprotease 9 is a prognostic marker in childhood acute lymphoblastic leukemia.
Schneider P; Costa O; Legrand E; Bigot D; Lecleire S; Grassi V; Vannier JP; Vasse M
Leuk Res; 2010 Jan; 34(1):24-31. PubMed ID: 19748669
[TBL] [Abstract] [Full Text] [Related]
16. Expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (timp-1) in tissues with a diagnosis of childhood lymphoma.
Bozkurt C; Ertem U; Oksal A; Sahin G; Yüksek N; Birgen D
Pediatr Hematol Oncol; 2008 Sep; 25(7):621-9. PubMed ID: 18850474
[TBL] [Abstract] [Full Text] [Related]
17. Plasma MMP-2-timp-2 complex levels measured during follow-up predict a risk of relapse in patients with malignant lymphoma.
Pennanen H; Kuittinen O; Turpeenniemi-Hujanen T
Eur J Haematol; 2008 Jan; 80(1):46-54. PubMed ID: 18028436
[TBL] [Abstract] [Full Text] [Related]
18. Gene profiling in anaplastic large-cell lymphoma-derived cell lines with cDNA expression arrays.
Gaiser T; Thorns C; Merz H; Noack F; Feller AC; Lange K
J Hematother Stem Cell Res; 2002 Apr; 11(2):423-8. PubMed ID: 11983114
[TBL] [Abstract] [Full Text] [Related]
19. Plasma erythropoietin in essential thrombocythaemia: at diagnosis and in response to myelosuppressive treatment.
Andréasson B; Lindstedt G; Kutti J
Leuk Lymphoma; 2000 Jun; 38(1-2):113-20. PubMed ID: 10811453
[TBL] [Abstract] [Full Text] [Related]
20. Serum erythropoietin and thrombopoietin levels in patients with essential thrombocythaemia.
Griesshammer M; Kubanek B; Beneke H; Heimpel H; Bangerter M; Bergmann L; Schrezenmeier H
Leuk Lymphoma; 2000 Feb; 36(5-6):533-8. PubMed ID: 10784398
[TBL] [Abstract] [Full Text] [Related]
[Next]
